Short answer
In controlled studies, noticeable changes after oral ayahuasca often began within the first hour, peaked after about one and a half to two hours, and the main acute phase lasted about four hours. This is a description of group observations, not a universal schedule: sample composition, metabolism, and study conditions significantly alter the time profile. These limits may vary from person to person.
When the noticeable effects usually start
After ingestion, the active components must pass through the digestive system, be absorbed and enter the bloodstream. This process does not happen instantly. In controlled research on orally administered ayahuasca, the first subjective changes usually appeared after 30-60 minutes. The researchers observed the group under standardized conditions, so this range describes exactly their sample and preparation.
The beginning is difficult to identify from a single sign. For some, the first noticeable change is a bodily sensation, for others, a change in attention, emotional tone, or visual perception. The questionnaire captures the moment when the participant is already able to name the difference, but does not measure the exact second of the beginning of each molecular process.
Acute phase begins gradually. Plasma concentrations of DMT and beta-carbolines increase according to their own curves, and the subjective response may slightly lag or lead the individual laboratory measurement. That is why correct publications provide several time points, and not one universal number.
When the intensity can be greatest
In the study by Riba et al., peak scores on several scales occurred at approximately 90-120 minutes. This broadly aligned with pharmacokinetic observations, although the timing did not match exactly. Various indicators - visual changes, emotional activation, bodily sensations - did not necessarily peak at the same time.
Peak subjective intensity is not a single instantaneous event. Rather, we are talking about the segment during which the total scores are the highest. Even in a controlled sample, individual curves differed. Averaging helps you see the overall shape, but hides some of the spread between people.
The article about the mechanism of action of ayahuasca explains more about why the concentration of the substance and the experience are not the same indicator. It also shows why the temporal profile depends on the interaction of several components and not just on the presence of DMT.
How long can the main experience last
In early controlled studies, subjective scores approached baseline after about four hours. Some reviews describe the acute period as several hours, but the exact limit depends on which measure is chosen: self-report, behavioral test, physiological parameter, or plasma concentration.
The main acute experience should be distinguished from the entire time during which a person feels different from usual. After the intensity decreases, fatigue, difficulty falling asleep, emotional openness, or the need to make sense of events may remain. Such phenomena do not continue the acute phase unchanged.
Popular descriptions often name a single duration without explaining where it came from. Scientifically, it is more careful to specify the preparation, the method of measurement, the sample and the moment of the last observation. If a study has ended active measurement after a certain time, this does not mean that every possible effect has necessarily ended at that time.
Why are the time limits different?
The time curve is formed by more than one factor. The composition of the sample determines which alkaloids and in what proportions enter the body. Individual metabolism affects the rate of absorption, conversion, and excretion. A separate role is played by the state of the digestive system, other substances in the body, and the way in which researchers record the beginning and end of the effect.
- botanical and chemical profile of a specific material;
- speed of passage through the digestive system and absorption;
- activity of enzymes involved in metabolism;
- physical and mental state of a person during observation;
- method and frequency of measurements in the study.
A separate article about the composition of ayahuasca helps to understand the first point. The name does not guarantee the same concentrations, so even a well-conducted study of one preparation does not establish the exact time for all materials that share the same name.
Why residual impressions are not equal to the effects of substances
Aftereffects may last longer than the most intense pharmacological changes. A person remembers events, attaches importance to them, reacts to lack of sleep or physical exertion. This is why it is important to distinguish acute effects from subsequent well-being, rather than combining them into one continuous phase.
The pharmacokinetic curve shows how the measured concentration changes. It does not measure memory, event evaluation, or the influence of expectations. Even when concentration is significantly reduced, emotional interpretation may remain active. The opposite is also possible: the substance is still detectable in laboratory tests, but the person no longer describes intense subjective changes.
In the material about the possible effects of ayahuasca this distinction is explained in more detail. Such a distinction protects against two errors: it does not minimize the persistent distress, and at the same time it does not attribute every subsequent thought to the direct action of the substance.
What pharmacokinetic studies show
Human studies have shown that DMT, harmine, harmaline and their metabolites have different concentration profiles. Studies from 1999, 2003, and 2012 helped correlate these profiles with participants’ reports over time. However, small samples and specific preparations limit the accuracy of generalizations.
Modern studies of standardized formulations provide more precise control over the ratio of active substances. This is useful for pharmacology: the researcher knows better what exactly the participant received. But standardized formulation and herbal decoction are not interchangeable. The results of the first do not automatically determine how long the second will act.
The time to maximum concentration cannot be read as a universal moment of the strongest experience either. The correlation between the two curves can be noticeable, but the subjective evaluation is influenced by the dynamics of interaction with the molecular targets, attention, context, and the way the question is asked. Scientific description preserves this uncertainty.
The frequency of blood sampling and surveys is important. If the indicators are recorded once an hour, the true maximum could have occurred between the two measurements. More frequent measurements give a more detailed curve, but increase the load on the participant and may affect their attention. Therefore, two studies using similar preparations sometimes show different peak times simply because of a different protocol.
Researchers are also analyzing metabolites. Their appearance shows the ways in which the body converted the original substances and helps to explain the differences between the participants. However, the presence of a metabolite does not establish the duration of the experience: its presence does not tell what exactly a person felt at that moment and how intense the reaction was.
How to compare time data of different publications
Before comparing the two numbers, you need to find out what exactly the authors called duration. In one work, this may be the time until the subjective scale score returns to baseline, in another, it may be the period during which the concentration remained measurable. The review sometimes compresses several such definitions into a convenient range. Without an explanation of the methods, the same numbers can mean different phenomena.
Next, it is worth checking the characteristics of the participants. Early experiments often involved healthy volunteers with prior experience, while another sample may consist of people without such experience. Age, physical condition and exclusion criteria also change the composition of the group. The average of one small sample should not be taken as an accurate prediction for any individual.
The third question concerns the preparation used. The publication should describe whether the plant material with the measured alkaloids, a standardized liquid, or a separately formulated combination of substances was examined. If the composition is unknown, explaining the time difference is much more difficult. If it is known, the conclusion still applies primarily to this material.
Finally, you need to look at the duration of the observation itself. A study that actively interviewed participants for four hours better describes the acute phase than the morning after. Follow-up studies may later reveal a different sense of well-being, but not with the same temporal precision. Both designs are useful as long as their tasks are not confused.
The practical conclusion for the reader is simple: trust not the most precise-looking number, but the most transparent description. A well-reported source tells who was observed, what was known about the composition, when the measurements were made, and exactly what phenomenon was considered complete. Such context is more important than the difference of a few tens of minutes between two average values.
What is confirmed and what remains unknown
The general pattern of the acute response under controlled conditions has been fairly consistently confirmed: a gradual onset over the first hour, a peak in intensity around one and a half to two hours, and a subsequent attenuation over several hours. It is also known that the metabolism of DMT is altered in the presence of beta-carbolines.
The exact boundaries for different botanical materials, people with co-morbid conditions, and situations outside the research setting remain less defined. Early works involved small, selected groups. The new standardized preparations reduce chemical uncertainty, but at the same time further distance themselves from the diversity of plant samples.
Therefore, the most accurate answer to the question "how long" consists of a range, a description of the source, and a clear explanation of variability. One number is convenient for a headline, but not enough to understand the real dynamics. It is especially important not to confuse the moment of greatest intensity, the end of the acute phase, and the return of normal well-being: these are three separate research questions.
Sources
- Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics (2003).
- Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers (1999).
- Metabolism and disposition of ayahuasca alkaloids in healthy volunteers (2012).
- DMT and harmine standardized formulation study (2024).
- Pharmacokinetic study of a standardized combination (2025).